EUVIMEDEUVIMED entdecken
Crossref

Unraveling the active ingredients and molecular mechanisms of Qinghua Changyan granule against irritable bowel syndrome with diarrhea: Effects on gut microbiota and glutamine transport via an integrative approach combining UHPLC-MS/MS and experimental verification

Jiayu Yang, Yuchen Wang, Shirong Wang, Zikun Liu, Xiao Chen, Rong Jia, Jie Wang, Feixia Wang, Qin Yang, Li Tang, Weifeng Miao

Fitoterapia · 2026-01 · 188 · 106960

DOI: 10.1016/j.fitote.2025.106960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fitoterapia, 2026-01. Verfasst von Jiayu Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Drugs, Chinese Herbal, Irritable Bowel Syndrome, Diarrhea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irritable bowel syndrome with diarrhea (IBS-D) is a prevalent functional gut disorder, with conventional treatments limited by incomplete symptom relief and side effects. Qinghua Changyan Granules (QHCYG), a traditional Chinese medicine, has clinical efficacy in treating IBS-D, though its molecular mechanisms are unclear. This study aimed to elucidate these mechanisms. Key components of QHCYG were identified via UHPLC-MS/MS and network pharmacology, with quercetin, kaempferol, luteolin, naringenin, and nobiletin confirmed as major active components. Pharmacodynamic results showed QHCYG significantly ameliorated IBS-D-related symptoms, including reduced fecal water content, diarrhea frequency, Bristol stool scale scores, and visceral hypersensitivity. Furthermore, QHCYG restored gut microbial diversity, increased the abundance of beneficial taxa (Akkermansia, Bifidobacterium) and decreased Allobaculum proportion; it also upregulated the expression of key intestinal barrier proteins, including zonula occludens-1 (ZO-1), epithelial cadherin (E-cadherin), catenin beta-1 (β-catenin), Claudin-1. Molecular docking indicated QHCYG's active components could bind to alanine-serine-cysteine-preferring transporter 2 (ASCT2), and QHCYG further elevated intestinal glutamine concentrations and ASCT2 expression. Notably, depletion of gut microbiota by antibiotics abolished all these therapeutic effects, confirming a microbiota-dependent mechanism. In conclusion, QHCYG alleviates IBS-D through restoring gut microbiota, enhancing intestinal barrier function, and promoting ASCT2-mediated glutamine transport, revealing a "Microbiota-Glutamine axis-Intestinal barrier" multi-target regulatory mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDrugs, Chinese HerbalIrritable Bowel SyndromeDiarrheaGlutamineAnimalsMolecular Docking SimulationTandem Mass SpectrometryMaleChromatography, High Pressure LiquidRats, Sprague-DawleyRatsPhytochemicalsNetwork PharmacologyKaempferolsFlavanones

Stichwörter der Autor:innen

GlutamineIntestinal barrierIrritable bowel syndromeMicrobiotaQinghua Changyan granules

Substanzen

Drugs, Chinese HerbalGlutaminenaringeninkaempferolPhytochemicalsKaempferolsFlavanones

Autor:innen und Institutionen

  • Department of Gastroenterology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China.
  • Department of Gastroenterology, Binhai County Hospital of Chinese Medicine, Yancheng 224500, China.
  • Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Material Medical, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Department of Gastroenterology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China. Electronic address: yangqin69@163.com.
  • Department of Gastroenterology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China. Electronic address: tang-tl@hotmail.com.
  • Department of Gastroenterology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China. Electronic address: miaoweifeng007@163.com.

Zitieren

APA

Yang, J., Wang, Y., Wang, S., Liu, Z., Chen, X., Jia, R., Wang, J., Wang, F., Yang, Q., Tang, L., & Miao, W. (2026). Unraveling the active ingredients and molecular mechanisms of Qinghua Changyan granule against irritable bowel syndrome with diarrhea: Effects on gut microbiota and glutamine transport via an integrative approach combining UHPLC-MS/MS and experimental verification. Fitoterapia, 188, 106960. https://doi.org/10.1016/j.fitote.2025.106960

Vancouver

Yang J, Wang Y, Wang S, Liu Z, Chen X, Jia R, et al. Unraveling the active ingredients and molecular mechanisms of Qinghua Changyan granule against irritable bowel syndrome with diarrhea: Effects on gut microbiota and glutamine transport via an integrative approach combining UHPLC-MS/MS and experimental verification. Fitoterapia. 2026;188:106960. doi:10.1016/j.fitote.2025.106960

BibTeX
@article{Yang2026,
  author = {Yang, Jiayu and Wang, Yuchen and Wang, Shirong and Liu, Zikun and Chen, Xiao and Jia, Rong and Wang, Jie and Wang, Feixia and Yang, Qin and Tang, Li and Miao, Weifeng},
  title = {Unraveling the active ingredients and molecular mechanisms of Qinghua Changyan granule against irritable bowel syndrome with diarrhea: Effects on gut microbiota and glutamine transport via an integrative approach combining UHPLC-MS/MS and experimental verification},
  journal = {Fitoterapia},
  year = {2026},
  volume = {188},
  pages = {106960},
  doi = {10.1016/j.fitote.2025.106960}
}
Kostenlos starten →